by Olwen Reina | Jul 5, 2017 | Disease Models
You’re in a bakery full of delicious treats. After a lot of soul-searching, you set your heart on a pecan danish. You reach for your wallet. But wait – how did you go from deciding how wanted your wallet to having your wallet in your hand? Thank your motor...
by Allison Kennedy | Dec 16, 2022 | Citation Alerts
Tempo-iMG™ and Tempo-iOligo™ were cited by scientists in a nature.com study where they built a 3D in vitro organoid model of the blood brain barrier (BBB). They chose to build their BBB model based on a composition of multiple neural and glial cell types. By utilizing...
by Karen O'Hanlon Cohrt | May 2, 2018 | Trends
We gave you an introduction to mesenchymal cells (MSCs) in one of our earlier Cell of the Month posts. Staying with the theme of recapitulating in vivo development processes (check out our most recent post on organoids), we wanted to take a closer look at MSCs and...
by Karen O'Hanlon Cohrt | May 25, 2018 | Trends
In simple terms, cancer organoids are organoids that are generated from cells donated by cancer patients. In our previous post about organoids, we described their many uses and applications, ranging from disease models, drug and toxicity testing, tissue and organ...
by Karen O'Hanlon Cohrt | Jun 18, 2018 | Trends
In addition to their potential for cellular therapy and modeling of developmental processes and disease, mesenchymal cells (MSCs) are rapidly gaining traction in cancer therapy. Although they are not the only stem cells with anti-cancer activity, MSCs are often...
